Specialized Melanoma Treatment Solutions for Unique Operational Environments
Legal Citation
Summary of the Inventive Concept
The present inventive concept adapts the original melanoma treatment method using dapansutrile for specific, narrow markets or unique operational environments, addressing high-security needs, disaster relief, extreme weather conditions, and other niche scenarios.
Background and Problem Solved
The original patent disclosed a method for treating melanoma using dapansutrile. However, it did not address the challenges of administering this treatment in high-security environments, disaster-stricken areas, or extreme weather conditions. The present inventive concept solves this problem by providing specialized solutions tailored to these unique operational environments.
Detailed Description of the Inventive Concept
The inventive concept comprises four main variations: (1) a secure, tamper-evident delivery system for high-security environments; (2) a dapansutrile-based treatment module designed for disaster relief in extreme weather conditions; (3) a portable, weather-resistant dapansutrile delivery device for remote, extreme-weather locations; and (4) a kit for treating melanoma in high-altitude, low-oxygen environments. Each variation is tailored to address the specific challenges of its target operational environment.
Novelty and Inventive Step
The present inventive concept introduces novel features not present in the original patent, including secure delivery systems, disaster relief modules, and portable delivery devices designed for extreme weather conditions. These features provide a non-obvious solution to the problem of administering melanoma treatment in unique operational environments.
Alternative Embodiments and Variations
Other embodiments of the inventive concept could include adapting the treatment module for use in high-temperature or high-humidity environments, or integrating the dapansutrile delivery device with other medical equipment for disaster relief scenarios.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the fields of disaster relief, high-security medical services, and extreme weather condition medical response. Target industries include government agencies, non-profit organizations, and private companies operating in these niches.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Oncological pharmacology and medical treatment methods, specifically melanoma therapeutics, requiring advanced knowledge of pharmaceutical formulation, drug delivery systems, and medical treatment protocols
Person of Ordinary Skill (PHOSITA) Profile
A medical researcher or pharmaceutical development specialist with expertise in oncology, drug delivery technologies, and clinical treatment adaptation for specialized environments, holding advanced degrees in pharmacology or medical sciences
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core melanoma treatment method using dapansutrile, applying standard pharmaceutical engineering techniques to adapt drug delivery for specific operational contexts. The disclosed variations demonstrate routine problem-solving approaches typical in medical technology adaptation, utilizing known design principles for specialized treatment scenarios. Each variation maintains the fundamental treatment method while introducing contextual modifications that would be considered obvious design choices within pharmaceutical engineering.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,529 |
|---|---|
| Title | Methods for treating melanoma |
| Assignee(s) | OLATEC THERAPEUTICS, INC. |